ATE419361T1 - Menschliche monoklonale antikörper spezifisch für antigen e2 des hepatitis c virus - Google Patents
Menschliche monoklonale antikörper spezifisch für antigen e2 des hepatitis c virusInfo
- Publication number
- ATE419361T1 ATE419361T1 AT97920721T AT97920721T ATE419361T1 AT E419361 T1 ATE419361 T1 AT E419361T1 AT 97920721 T AT97920721 T AT 97920721T AT 97920721 T AT97920721 T AT 97920721T AT E419361 T1 ATE419361 T1 AT E419361T1
- Authority
- AT
- Austria
- Prior art keywords
- antigen
- monoclonal antibodies
- hcv
- molecules
- hepatitis
- Prior art date
Links
- 241000711549 Hepacivirus C Species 0.000 title abstract 6
- 239000000427 antigen Substances 0.000 title abstract 2
- 102000036639 antigens Human genes 0.000 title abstract 2
- 108091007433 antigens Proteins 0.000 title abstract 2
- 102000008482 12E7 Antigen Human genes 0.000 abstract 2
- 108010020567 12E7 Antigen Proteins 0.000 abstract 2
- 230000027455 binding Effects 0.000 abstract 2
- 102000039446 nucleic acids Human genes 0.000 abstract 2
- 108020004707 nucleic acids Proteins 0.000 abstract 2
- 150000007523 nucleic acids Chemical class 0.000 abstract 2
- 229920001184 polypeptide Polymers 0.000 abstract 2
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 2
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 2
- 108060003951 Immunoglobulin Proteins 0.000 abstract 1
- 238000001261 affinity purification Methods 0.000 abstract 1
- 239000013604 expression vector Substances 0.000 abstract 1
- 239000012634 fragment Substances 0.000 abstract 1
- 102000018358 immunoglobulin Human genes 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 238000000159 protein binding assay Methods 0.000 abstract 1
- 230000009870 specific binding Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
- C07K16/1081—Togaviridae, e.g. flavivirus, rubella virus, hog cholera virus
- C07K16/109—Hepatitis C virus; Hepatitis G virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/42—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum viral
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Virology (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Communicable Diseases (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Molecular Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Oncology (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/635,109 US6538114B1 (en) | 1996-04-19 | 1996-04-19 | Human monoclonal antibodies specific for hepatitis C virus (HCV) E2 antigen |
US08/844,215 US6747136B2 (en) | 1996-04-19 | 1997-04-17 | Human monoclonal antibodies specific for hepatitis C virus (HCV) E2 antigen |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE419361T1 true ATE419361T1 (de) | 2009-01-15 |
Family
ID=27092301
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT97920721T ATE419361T1 (de) | 1996-04-19 | 1997-04-18 | Menschliche monoklonale antikörper spezifisch für antigen e2 des hepatitis c virus |
Country Status (8)
Country | Link |
---|---|
US (1) | US6747136B2 (de) |
EP (1) | EP0937153B1 (de) |
AT (1) | ATE419361T1 (de) |
CA (1) | CA2262423C (de) |
DE (1) | DE69739187D1 (de) |
DK (1) | DK0937153T3 (de) |
ES (1) | ES2320051T3 (de) |
WO (1) | WO1997040176A1 (de) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000005266A1 (en) * | 1998-07-21 | 2000-02-03 | Connex Gesellschaft Zur Optimierung Von Forschung Und Entwicklung Mbh | Anti hepatitis c virus antibody and uses thereof |
US7091324B2 (en) * | 1998-11-05 | 2006-08-15 | Board Of Trustees Of Leland Stanford Junior University | Prevention and treatment of HCV infection employing antibodies directed against conformational epitopes |
WO2000026418A1 (en) * | 1998-11-05 | 2000-05-11 | The Board Of Trustees Of Leland Stanford Junior University | Human pan-hcv human monoclonal antibodies |
DE19919585A1 (de) | 1999-04-29 | 2000-12-07 | Cmi Ag | Verwendung von Phyllanthus zur Behandlung von oxidativem Streß und anderen Symptomen |
JP5498637B2 (ja) * | 1999-07-28 | 2014-05-21 | ノバルティス バクシンズ アンド ダイアグノスティックス,インコーポレーテッド | C型肝炎ウイルス抗原免疫アッセイ検出システム |
US6815160B1 (en) | 1999-07-28 | 2004-11-09 | Chiron Corporation | Hepatitis C viral antigen immunoassay detection systems |
IL137522A (en) * | 2000-07-26 | 2007-06-17 | Drk Blutspendediendst Baden Wu | HCV human monoclonal antibody E2 glycoprotein antibody |
WO2002055560A2 (en) * | 2000-12-01 | 2002-07-18 | The Gouvernment Of The United States Of America, As Represented By The Secretary Department Of Health And Human Services | Monoclonal antibodies specific for the e2 glycoprotein of hepatitis c virus and their use in the diagnosis, treatment, and prevention of hepatitis c |
JP4860098B2 (ja) | 2000-12-18 | 2012-01-25 | ダイアックス、コープ | 遺伝的パッケージの焦点を合わせたライブラリー |
EP1355948B1 (de) * | 2001-01-12 | 2009-03-11 | Molecules of Man AB | Materialien und methoden zur behandlung von hepatitis c |
WO2002059340A1 (en) * | 2001-01-26 | 2002-08-01 | The Scripps Research Institute | Immunopolypeptides to hepatitis c virus |
US20070178065A1 (en) * | 2002-05-03 | 2007-08-02 | Lattime Edmund C | Neutralizing factors as vaccine adjuvants |
JP4601427B2 (ja) * | 2002-09-18 | 2010-12-22 | ザ・トラステイーズ・オブ・ザ・ユニバーシテイ・オブ・ペンシルベニア | 細胞上および生物学的混合物中の抗原の検出のための組成物、方法およびキット |
AU2008223561B2 (en) | 2007-02-21 | 2013-10-03 | University Of Massachusetts | Human antibodies against hepatitis C virus (HCV) uses thereof |
US20100104555A1 (en) * | 2008-10-24 | 2010-04-29 | The Scripps Research Institute | HCV neutralizing epitopes |
WO2011147863A1 (en) | 2010-05-25 | 2011-12-01 | INSERM (Institut National de la Santé et de la Recherche Médicale) | Combination of anti-envelope antibodies and anti-receptor antibodies for the treatment and prevention of hcv infection |
CN115028711B (zh) * | 2021-05-08 | 2024-02-09 | 南昌大学 | 一种高亲和力抗丙型肝炎病毒的全人源单克隆抗体及其用途 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5308750A (en) | 1989-12-22 | 1994-05-03 | Abbott Laboratories | Monoclonal antibodies to putative HCV E2/NS1 proteins and methods for using same |
EP0447984A1 (de) | 1990-03-20 | 1991-09-25 | Abbott Laboratories | Hyperimmunglobulin gegen Hepatitis-C-Virus und Verfahren zur Herstellung |
EP0585287B1 (de) | 1990-07-10 | 1999-10-13 | Cambridge Antibody Technology Limited | Verfahren zur herstellung von spezifischen bindungspaargliedern |
FR2677372B1 (fr) * | 1991-06-06 | 1994-11-10 | Pasteur Institut | Sequences nucleotidiques et peptidiques d'un isolat de virus de l'hepatite c, applications diagnostiques et therapeutiques. |
WO1993006213A1 (en) | 1991-09-23 | 1993-04-01 | Medical Research Council | Production of chimeric antibodies - a combinatorial approach |
-
1997
- 1997-04-17 US US08/844,215 patent/US6747136B2/en not_active Expired - Fee Related
- 1997-04-18 DE DE69739187T patent/DE69739187D1/de not_active Expired - Lifetime
- 1997-04-18 AT AT97920721T patent/ATE419361T1/de not_active IP Right Cessation
- 1997-04-18 CA CA2262423A patent/CA2262423C/en not_active Expired - Lifetime
- 1997-04-18 DK DK97920721T patent/DK0937153T3/da active
- 1997-04-18 WO PCT/EP1997/001977 patent/WO1997040176A1/en active Application Filing
- 1997-04-18 ES ES97920721T patent/ES2320051T3/es not_active Expired - Lifetime
- 1997-04-18 EP EP97920721A patent/EP0937153B1/de not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
CA2262423A1 (en) | 1997-10-30 |
US20020016445A1 (en) | 2002-02-07 |
DK0937153T3 (da) | 2009-05-04 |
US6747136B2 (en) | 2004-06-08 |
ES2320051T3 (es) | 2009-05-18 |
EP0937153A1 (de) | 1999-08-25 |
DE69739187D1 (de) | 2009-02-12 |
EP0937153B1 (de) | 2008-12-31 |
CA2262423C (en) | 2010-08-03 |
WO1997040176A1 (en) | 1997-10-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE419361T1 (de) | Menschliche monoklonale antikörper spezifisch für antigen e2 des hepatitis c virus | |
ATE425989T1 (de) | Proteinreinigungsverfahren | |
Tissot et al. | Two-dimensional polyacrylamide gel electrophoresis analysis of cryoglobulins and identification of an IgM-associated peptide | |
DK1129190T3 (da) | Human TSLP DNA og polypeptider | |
NO20025354L (no) | Pattedyr-reseptorproteiner; beslektede reagenser og fremgangsmåter | |
ATE318309T1 (de) | Hcv-spezifische peptide, mittel dazu und ihre verwendung | |
MX9603637A (es) | Purificacion de anticuerpo. | |
AU2001294541A1 (en) | Mammalian genes; related reagents and methods | |
HUP0003513A2 (hu) | Apoptózist indukáló monoklonális antitest | |
HUP0004639A2 (hu) | Chlamydia fehérje, génszekvencia és ezek alkalmazása | |
RU2008100239A (ru) | Терапевтические связывающие молекулы в виде химерного антитела | |
MX347175B (es) | Anticuerpos igm humanos con la capacidad de inducir remielinacion, y usos diagnosticos y terapeuticos de los mismos particularmente en el sistema nervioso central. | |
ATE380867T1 (de) | Lactoferrinrezeptorgen von moraxella | |
ATE148168T1 (de) | Monoklonale antikörper | |
DE69735207D1 (de) | Neuartiges, fibrinogen-bindendes protein, welches von einem koagulase-negativen staphylokokkus abstammt | |
ATE370235T1 (de) | Rekombinantpeptide hergeleitet vom mc3 antikörper gegen ba46, verfahren zu deren verwendung und verfahren zur humanisierung von antikörperpeptiden | |
EA201001190A1 (ru) | Выделенное антитело, специфически связанное с полипептидом, состоящее из последовательности аминокислотных остатков | |
KR960705038A (ko) | 자기 면역 질환에 관련된 프로토콜에서 미엘린 올리고덴드로시트 당 단백질 및 그의 펩타이드 부분들의 용도(users of myelin oligodendrocyte glycoprotein and peptide portions thereof in protocols related to autoimmune desease) | |
DE69435059D1 (de) | Immunoreaktive antigene des hepatitis e viruses | |
DE60041697D1 (de) | Säugetier-rezeptorproteine; ähnliche reagentien und methoden | |
FR2560212B1 (fr) | Anticorps monoclonaux contre l'interferon a2 et hybridomes produisant de tels anticorps | |
ATE191568T1 (de) | Spezifische bindungssubstanzen für antikörper und deren verwendung für immunoassays oder vakzine | |
DE69736158D1 (de) | Glutamine: Fructose-6-Phosphat Amidotransferase (GFAT), ihre Herstellung und Verwendung | |
ATE190491T1 (de) | Peptide als diagnose- und therapiemittel für spondyloarthropathien | |
SE9704141D0 (sv) | New protein and nucleotide sequence, encoding said protein |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |